Abdallah Marey Aboshhran, et al. “PUBLIC INTEREST IN THE OFF-LABEL USE OF GLUCAGON-LIKE PEPTIDE 1 AGONISTS (OZEMPIC) FOR COSMETIC WEIGHT LOSS‏”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 30, no. 2, Feb. 2023, pp. 745-7, https://doi.org/10.53555/jptcp.v30i2.4746.